{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T05:32:37Z","timestamp":1782970357366,"version":"3.54.5"},"reference-count":116,"publisher":"MDPI AG","issue":"13","license":[{"start":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T00:00:00Z","timestamp":1782259200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>Circulating ketone bodies (KBs), particularly \u03b2-hydroxybutyrate (\u03b2-HB), have emerged as metabolites with dual roles as both oxidative fuels and metabolic signaling molecules. Beyond serving as an alternative energy substrate, \u03b2-HB regulates diverse pathways involved in oxidative stress, inflammation, and mitochondrial function. However, the clinical implications of circulating KBs remain uncertain. This review summarizes current evidence regarding the potential role of KBs in glycemic progression and diabetic cardiomyopathy (DCM). Epidemiologic and experimental studies report conflicting associations between KB levels and the progression to hyperglycemia or type 2 diabetes, with some findings suggesting that elevated KB levels may reflect a metabolically favorable phenotype or a compensatory mechanism, whereas others indicate links to worsening glycemia. Similarly, studies in DCM have produced divergent results, with \u03b2-HB reported to improve mitochondrial function and cardiac performance in some models while contributing to metabolic inflexibility and adverse cardiac remodeling in others. We discuss potential mechanisms underlying these discrepancies and propose that the metabolic effects of \u03b2-HB are context-dependent, influenced by factors such as circulating concentration, the mode of ketosis induction, and the underlying metabolic or disease stage. Understanding these contextual determinants may help clarify whether \u03b2-HB represents an adaptive metabolic signal or a maladaptive substrate shift in cardiometabolic disease.<\/jats:p>","DOI":"10.3390\/ijms27135716","type":"journal-article","created":{"date-parts":[[2026,6,25]],"date-time":"2026-06-25T05:48:16Z","timestamp":1782366496000},"page":"5716","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Circulating \u03b2-Hydroxybutyrate in Glycemic Progression and Diabetic Cardiomyopathy: Adaptive Signal or Maladaptive Substrate?"],"prefix":"10.3390","volume":"27","author":[{"given":"So Ra","family":"Kim","sequence":"first","affiliation":[{"name":"Division of Endocrinology and Metabolism, Department of Internal Medicine, Yonsei University College of Medicine, Seoul 03722, Republic of Korea"},{"name":"Institute of Endocrine Research, Yonsei University College of Medicine, Seoul 03722, Republic of Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9899-4992","authenticated-orcid":false,"given":"Byung-Wan","family":"Lee","sequence":"additional","affiliation":[{"name":"Division of Endocrinology and Metabolism, Department of Internal Medicine, Yonsei University College of Medicine, Seoul 03722, Republic of Korea"},{"name":"Institute of Endocrine Research, Yonsei University College of Medicine, Seoul 03722, Republic of Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,6,24]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","unstructured":"Yoo, B.M., Kim, S.R., and Lee, B.W. (2025). Ketone body induction: Insights into metabolic disease management. Biomedicines, 13.","DOI":"10.3390\/biomedicines13061484"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.2337\/dc16-0542","article-title":"Can a shift in fuel energetics explain the beneficial cardiorenal outcomes in the empa-reg outcome study? A unifying hypothesis","volume":"39","author":"Mudaliar","year":"2016","journal-title":"Diabetes Care"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.2337\/dc16-0330","article-title":"Cv protection in the empa-reg outcome trial: A \u201cthrifty substrate\u201d hypothesis","volume":"39","author":"Ferrannini","year":"2016","journal-title":"Diabetes Care"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"1606","DOI":"10.1093\/cvr\/cvz045","article-title":"Increased ketone body oxidation provides additional energy for the failing heart without improving cardiac efficiency","volume":"115","author":"Ho","year":"2019","journal-title":"Cardiovasc. Res."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1038\/s44161-023-00259-1","article-title":"Ketones and the cardiovascular system","volume":"2","author":"Lopaschuk","year":"2023","journal-title":"Nat. Cardiovasc. Res."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1038\/nm.3804","article-title":"The ketone metabolite \u03b2-hydroxybutyrate blocks nlrp3 inflammasome-mediated inflammatory disease","volume":"21","author":"Youm","year":"2015","journal-title":"Nat. Med."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1126\/science.1227166","article-title":"Suppression of oxidative stress by \u03b2-hydroxybutyrate, an endogenous histone deacetylase inhibitor","volume":"339","author":"Shimazu","year":"2013","journal-title":"Science"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1146\/annurev-nutr-071816-064916","article-title":"\u0392-hydroxybutyrate: A signaling metabolite","volume":"37","author":"Newman","year":"2017","journal-title":"Annu. Rev. Nutr."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/j.cmet.2016.12.022","article-title":"Multi-dimensional roles of ketone bodies in fuel metabolism, signaling, and therapeutics","volume":"25","author":"Puchalska","year":"2017","journal-title":"Cell Metab."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"101395","DOI":"10.1016\/j.redox.2019.101395","article-title":"Ketone bodies, stress response, and redox homeostasis","volume":"29","author":"Tapia","year":"2020","journal-title":"Redox Biol."},{"key":"ref_11","doi-asserted-by":"crossref","unstructured":"Karamitsos, K., Oikonomou, E., Theofilis, P., Ikonomidis, I., Kassi, E., Lambadiari, V., Gialafos, E., Tsatsaragkou, A., Mystakidi, V.C., and Zisimos, K. (2025). The role of nlrp3 inflammasome in type 2 diabetes mellitus and its macrovascular complications. J. Clin. Med., 14.","DOI":"10.3390\/jcm14134606"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"3790721","DOI":"10.1155\/2022\/3790721","article-title":"The role of nlrp3 inflammasome in diabetic cardiomyopathy and its therapeutic implications","volume":"2022","author":"Ding","year":"2022","journal-title":"Oxid. Med. Cell. Longev."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1186\/s12933-016-0361-1","article-title":"Forkhead box transcription factor 1: Role in the pathogenesis of diabetic cardiomyopathy","volume":"15","author":"Kandula","year":"2016","journal-title":"Cardiovasc. Diabetol."},{"key":"ref_14","doi-asserted-by":"crossref","unstructured":"Wang, J., Xiao, M., Wang, J., Wang, S., Zhang, J., Guo, Y., Tang, Y., and Gu, J. (2021). Nrf2-related epigenetic modifications in cardiac and vascular complications of diabetes mellitus. Front. Endocrinol., 12.","DOI":"10.3389\/fendo.2021.598005"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"2463","DOI":"10.2337\/db22-0623","article-title":"Nrf2 and diabetes: The good, the bad, and the complex","volume":"71","author":"Dodson","year":"2022","journal-title":"Diabetes"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.tem.2013.09.002","article-title":"Ketone bodies as signaling metabolites","volume":"25","author":"Newman","year":"2014","journal-title":"Trends Endocrinol. Metab."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1146\/annurev.bi.49.070180.002143","article-title":"Regulation of hepatic fatty acid oxidation and ketone body production","volume":"49","author":"McGarry","year":"1980","journal-title":"Annu. Rev. Biochem."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"5175","DOI":"10.1172\/JCI76388","article-title":"Ketogenesis prevents diet-induced fatty liver injury and hyperglycemia","volume":"124","author":"Cotter","year":"2014","journal-title":"J. Clin. Investig."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.2337\/db15-1356","article-title":"Shift to fatty substrate utilization in response to sodium-glucose cotransporter 2 inhibition in subjects without diabetes and patients with type 2 diabetes","volume":"65","author":"Ferrannini","year":"2016","journal-title":"Diabetes"},{"key":"ref_20","doi-asserted-by":"crossref","unstructured":"Veneti, S., Grammatikopoulou, M.G., Kintiraki, E., Mintziori, G., and Goulis, D.G. (2023). Ketone bodies in diabetes mellitus: Friend or foe?. Nutrients, 15.","DOI":"10.3390\/nu15204383"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1007\/BF00266034","article-title":"Ketone bodies as markers for type 1 (insulin-dependent) diabetes and their value in the monitoring of diabetic control","volume":"26","author":"Harano","year":"1984","journal-title":"Diabetologia"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1007\/BF03349844","article-title":"High blood ketone body concentration in type 2 non-insulin dependent diabetic patients","volume":"19","author":"Avogaro","year":"1996","journal-title":"J. Endocrinol. Investig."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1007\/s00125-019-4829-x","article-title":"Spontaneous ketonuria and risk of incident diabetes: A 12 year prospective study","volume":"62","author":"Kim","year":"2019","journal-title":"Diabetologia"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1038\/s41387-025-00364-z","article-title":"Association between serum beta-hydroxybutyrate levels and risk of type 2 diabetes mellitus in patients with impaired fasting glucose","volume":"15","author":"Bae","year":"2025","journal-title":"Nutr. Diabetes"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"263","DOI":"10.3803\/EnM.2015.30.3.263","article-title":"Diabetes in asians","volume":"30","author":"Rhee","year":"2015","journal-title":"Endocrinol. Metab."},{"key":"ref_26","doi-asserted-by":"crossref","unstructured":"Bragg, F., Trichia, E., Aguilar-Ramirez, D., Be\u0161evi\u0107, J., Lewington, S., and Emberson, J. (2022). Predictive value of circulating nmr metabolic biomarkers for type 2 diabetes risk in the uk biobank study. BMC Med., 20.","DOI":"10.1186\/s12916-022-02354-9"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"1771","DOI":"10.3346\/jkms.2010.25.12.1771","article-title":"Ketonuria after fasting may be related to the metabolic superiority","volume":"25","author":"Joo","year":"2010","journal-title":"J. Korean Med. Sci."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.2337\/db22-0826","article-title":"Fasting ketone bodies and incident type 2 diabetes in the general population","volume":"72","author":"Garcia","year":"2023","journal-title":"Diabetes"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1172\/JCI104949","article-title":"Effect of infused ketone bodies on glucose utilization in the dog","volume":"43","author":"Felts","year":"1964","journal-title":"J. Clin. Investig."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"e00300","DOI":"10.1002\/edm2.300","article-title":"Exogenous d-\u03b2-hydroxybutyrate lowers blood glucose in part by decreasing the availability of l-alanine for gluconeogenesis","volume":"5","author":"Norwitz","year":"2022","journal-title":"Endocrinol. Diabetes Metab."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"3618","DOI":"10.2337\/db12-1363","article-title":"Association of ketone body levels with hyperglycemia and type 2 diabetes in 9398 finnish men","volume":"62","author":"Mahendran","year":"2013","journal-title":"Diabetes"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"2298","DOI":"10.1007\/s00125-019-05001-w","article-title":"Circulating metabolites and the risk of type 2 diabetes: A prospective study of 11,896 young adults from four finnish cohorts","volume":"62","author":"Mustelin","year":"2019","journal-title":"Diabetologia"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1507\/endocrj.EJ14-0431","article-title":"Age-related changes in the diurnal variation of ketogenesis in patients with type 2 diabetes and relevance to hypoglycemic medications","volume":"62","author":"Nakayama","year":"2015","journal-title":"Endocr. J."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/0168-8227(93)90023-X","article-title":"Insulin resistance in the regulation of lipolysis and ketone body metabolism in non-insulin dependent diabetes is apparent at very low insulin concentrations","volume":"20","author":"Singh","year":"1993","journal-title":"Diabetes Res. Clin. Pract."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"E1205","DOI":"10.1152\/ajpendo.2001.281.6.E1205","article-title":"Chronic exposure to \u03b2-hydroxybutyrate impairs insulin action in primary cultures of adult cardiomyocytes","volume":"281","author":"Tardif","year":"2001","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"E364","DOI":"10.1152\/ajpendo.00142.2010","article-title":"\u03b2-hydroxybutyrate inhibits insulin-mediated glucose transport in mouse oxidative muscle","volume":"299","author":"Yamada","year":"2010","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"ref_37","first-page":"1372","article-title":"Metabolic signatures of insulin resistance in 7098 young adults","volume":"61","author":"Soininen","year":"2012","journal-title":"Diabetes"},{"key":"ref_38","doi-asserted-by":"crossref","unstructured":"Garcia, E., Shalaurova, I., Matyus, S.P., Oskardmay, D.N., Otvos, J.D., Dullaart, R.P.F., and Connelly, M.A. (2020). Ketone bodies are mildly elevated in subjects with type 2 diabetes mellitus and are inversely associated with insulin resistance as measured by the lipoprotein insulin resistance index. J. Clin. Med., 9.","DOI":"10.3390\/jcm9020321"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.2337\/db08-1637","article-title":"Butyrate improves insulin sensitivity and increases energy expenditure in mice","volume":"58","author":"Gao","year":"2009","journal-title":"Diabetes"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"66444","DOI":"10.18632\/oncotarget.12119","article-title":"\u0392-hydroxybutyrate suppresses inflammasome formation by ameliorating endoplasmic reticulum stress via ampk activation","volume":"7","author":"Bae","year":"2016","journal-title":"Oncotarget"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1172\/JCI104925","article-title":"The hypoglycemic action of ketones. Ii. Evidence for a stimulatory feedback of ketones on the pancreatic beta cells","volume":"43","author":"Madison","year":"1964","journal-title":"J. Clin. Investig."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1038\/227384a0","article-title":"Ketone bodies and evidence for increased insulin secretion","volume":"227","author":"Jenkins","year":"1970","journal-title":"Nature"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"2606","DOI":"10.1172\/JCI107453","article-title":"Rapid intravenous sodium acetoacetate infusion in man Metabolic and kinetic responses","volume":"52","author":"Owen","year":"1973","journal-title":"J. Clin. Investig."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"C442","DOI":"10.1152\/ajpcell.00368.2007","article-title":"Acetoacetate and \u03b2-hydroxybutyrate in combination with other metabolites release insulin from ins-1 cells and provide clues about pathways in insulin secretion","volume":"294","author":"MacDonald","year":"2008","journal-title":"Am. J. Physiol. Cell Physiol."},{"key":"ref_45","first-page":"1584","article-title":"Long term exposure to fatty acids and ketones inhibits b-cell functions in human pancreatic islets of langerhans","volume":"80","author":"Zhou","year":"1995","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"E372","DOI":"10.1152\/ajpendo.00157.2004","article-title":"Chronic exposure to \u03b2-hydroxybutyrate inhibits glucose-induced insulin release from pancreatic islets by decreasing nadh contents","volume":"288","author":"Takehiro","year":"2005","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1186\/1743-7075-6-52","article-title":"Acute metabolic responses to a high-carbohydrate meal in outpatients with type 2 diabetes treated with a low-carbohydrate diet: A crossover meal tolerance study","volume":"6","author":"Haimoto","year":"2009","journal-title":"Nutr. Metab."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"1542","DOI":"10.1016\/j.metabol.2005.05.023","article-title":"Ketone body metabolism in lean and obese women","volume":"54","author":"Vice","year":"2005","journal-title":"Metabolism"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"E1103","DOI":"10.1152\/ajpendo.00613.2006","article-title":"Effects of fasting on insulin action and glucose kinetics in lean and obese men and women","volume":"293","author":"Bergman","year":"2007","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"1466","DOI":"10.1007\/s00125-008-1040-x","article-title":"Adipose tissue fatty acid metabolism in insulin-resistant men","volume":"51","author":"Bickerton","year":"2008","journal-title":"Diabetologia"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.1038\/oby.2008.678","article-title":"Effects of insulin on ketogenesis following fasting in lean and obese men","volume":"17","author":"Soeters","year":"2009","journal-title":"Obesity"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1016\/j.cmet.2011.11.004","article-title":"Excessive hepatic mitochondrial tca cycle and gluconeogenesis in humans with nonalcoholic fatty liver disease","volume":"14","author":"Sunny","year":"2011","journal-title":"Cell Metab."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1194\/jlr.M023382","article-title":"Elevated tca cycle function in the pathology of diet-induced hepatic insulin resistance and fatty liver","volume":"53","author":"Satapati","year":"2012","journal-title":"J. Lipid Res."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"e127737","DOI":"10.1172\/jci.insight.127737","article-title":"Impaired ketogenesis and increased acetyl-coa oxidation promote hyperglycemia in human fatty liver","volume":"5","author":"Fletcher","year":"2019","journal-title":"JCI Insight"},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"e146","DOI":"10.1161\/CIR.0000000000000485","article-title":"Heart disease and stroke statistics\u20142017 update: A report from the american heart association","volume":"135","author":"Benjamin","year":"2017","journal-title":"Circulation"},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"2080","DOI":"10.1111\/bph.12475","article-title":"Mitochondrial fatty acid oxidation alterations in heart failure, ischaemic heart disease and diabetic cardiomyopathy","volume":"171","author":"Fillmore","year":"2014","journal-title":"Br. J. Pharmacol."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"1718","DOI":"10.1093\/eurheartj\/ehv134","article-title":"Clinical diabetic cardiomyopathy: A two-faced disease with restrictive and dilated phenotypes","volume":"36","author":"Paulus","year":"2015","journal-title":"Eur. Heart J."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/j.hfc.2019.02.003","article-title":"Diabetic cardiomyopathy: Definition, diagnosis, and therapeutic implications","volume":"15","author":"Paolillo","year":"2019","journal-title":"Heart Fail. Clin."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1016\/j.bbamcr.2012.08.014","article-title":"Targeting mitochondrial oxidative metabolism as an approach to treat heart failure","volume":"1833","author":"Fillmore","year":"2013","journal-title":"Biochim. Biophys. Acta (BBA) Mol. Cell Res."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1007\/s10741-013-9377-8","article-title":"Metabolic dysfunction in diabetic cardiomyopathy","volume":"19","author":"Isfort","year":"2014","journal-title":"Heart Fail. Rev."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.mce.2016.03.025","article-title":"Wogonin attenuates diabetic cardiomyopathy through its anti-inflammatory and anti-oxidative properties","volume":"428","author":"Khan","year":"2016","journal-title":"Mol. Cell. Endocrinol."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1186\/s12933-018-0767-z","article-title":"Mir-21 protected against diabetic cardiomyopathy induced diastolic dysfunction by targeting gelsolin","volume":"17","author":"Dai","year":"2018","journal-title":"Cardiovasc. Diabetol."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.2337\/diacare.13.11.1169","article-title":"Diabetic cardiomyopathy","volume":"13","author":"Fein","year":"1990","journal-title":"Diabetes Care"},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1159\/000481843","article-title":"H3 relaxin protects against myocardial injury in experimental diabetic cardiomyopathy by inhibiting myocardial apoptosis, fibrosis and inflammation","volume":"43","author":"Zhang","year":"2017","journal-title":"Cell. Physiol. Biochem."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1161\/CIRCRESAHA.121.318241","article-title":"Cardiac energy metabolism in heart failure","volume":"128","author":"Lopaschuk","year":"2021","journal-title":"Circ. Res."},{"key":"ref_66","first-page":"1","article-title":"Sglt2 inhibitors and ketone metabolism in heart failure","volume":"11","author":"Voorrips","year":"2022","journal-title":"J. Lipid Atheroscler."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"H1060","DOI":"10.1152\/ajpheart.00646.2012","article-title":"Ketone body metabolism and cardiovascular disease","volume":"304","author":"Cotter","year":"2013","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1016\/j.cardfail.2020.04.005","article-title":"Myocardial ketones metabolism in heart failure","volume":"26","author":"Karwi","year":"2020","journal-title":"J. Card. Fail."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1093\/cvr\/cvaa143","article-title":"Ketones can become the major fuel source for the heart but do not increase cardiac efficiency","volume":"117","author":"Ho","year":"2021","journal-title":"Cardiovasc. Res."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1161\/01.RES.0000137170.41939.d9","article-title":"Is the failing heart energy starved? On using chemical energy to support cardiac function","volume":"95","author":"Ingwall","year":"2004","journal-title":"Circ. Res."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1056\/NEJMra063052","article-title":"The failing heart\u2014An engine out of fuel","volume":"356","author":"Neubauer","year":"2007","journal-title":"N. Engl. J. Med."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"215re3","DOI":"10.1126\/scitranslmed.3007328","article-title":"Metabolic rates of atp transfer through creatine kinase (ck flux) predict clinical heart failure events and death","volume":"5","author":"Bottomley","year":"2013","journal-title":"Sci. Transl. Med."},{"key":"ref_73","doi-asserted-by":"crossref","unstructured":"Karwi, Q.G., Uddin, G.M., Ho, K.L., and Lopaschuk, G.D. (2018). Loss of metabolic flexibility in the failing heart. Front. Cardiovasc. Med., 5.","DOI":"10.3389\/fcvm.2018.00068"},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"3716","DOI":"10.1172\/JCI120849","article-title":"Mitochondrial dysfunction in pathophysiology of heart failure","volume":"128","author":"Zhou","year":"2018","journal-title":"J. Clin. Investig."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1161\/CIRCULATIONAHA.118.036259","article-title":"Mitochondrial dysfunction in heart failure with preserved ejection fraction","volume":"139","author":"Kumar","year":"2019","journal-title":"Circulation"},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"2191","DOI":"10.1161\/01.CIR.0000127959.28627.F8","article-title":"Effect of obesity and insulin resistance on myocardial substrate metabolism and efficiency in young women","volume":"109","author":"Peterson","year":"2004","journal-title":"Circulation"},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"1524","DOI":"10.1016\/j.jacc.2009.04.074","article-title":"Altered myocardial substrate metabolism and decreased diastolic function in nonischemic human diabetic cardiomyopathy: Studies with cardiac positron emission tomography and magnetic resonance imaging","volume":"54","author":"Rijzewijk","year":"2009","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1161\/01.CIR.0000083716.82622.FD","article-title":"Disruption of leptin signaling contributes to cardiac hypertrophy independently of body weight in mice","volume":"108","author":"Barouch","year":"2003","journal-title":"Circulation"},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"3483","DOI":"10.1210\/en.2003-0242","article-title":"Cardiac lipid accumulation associated with diastolic dysfunction in obese mice","volume":"144","author":"Christoffersen","year":"2003","journal-title":"Endocrinology"},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1093\/cvr\/cvu223","article-title":"Left ventricular diastolic dysfunction and myocardial stiffness in diabetic mice is attenuated by inhibition of dipeptidyl peptidase 4","volume":"104","author":"Hamdani","year":"2014","journal-title":"Cardiovasc. Res."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"H976","DOI":"10.1152\/ajpheart.00088.2002","article-title":"Echocardiographic assessment of cardiac function in diabetic db\/db and transgenic db\/db-hglut4 mice","volume":"283","author":"Semeniuk","year":"2002","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"ref_82","doi-asserted-by":"crossref","unstructured":"Li, R.J., Yang, J., Yang, Y., Ma, N., Jiang, B., Sun, Q.W., and Li, Y.J. (2014). Speckle tracking echocardiography in the diagnosis of early left ventricular systolic dysfunction in type ii diabetic mice. BMC Cardiovasc. Disord., 14.","DOI":"10.1186\/1471-2261-14-141"},{"key":"ref_83","doi-asserted-by":"crossref","unstructured":"Venardos, K., De Jong, K.A., Elkamie, M., Connor, T., and McGee, S.L. (2015). The pkd inhibitor cid755673 enhances cardiac function in diabetic db\/db mice. PLoS ONE, 10.","DOI":"10.1371\/journal.pone.0120934"},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1161\/01.HYP.25.2.235","article-title":"Cardiac glucose and fatty acid oxidation in the streptozotocin-induced diabetic spontaneously hypertensive rat","volume":"25","author":"Christe","year":"1995","journal-title":"Hypertension"},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1161\/CIRCRESAHA.107.150417","article-title":"Cardiac energy metabolism in obesity","volume":"101","author":"Lopaschuk","year":"2007","journal-title":"Circ. Res."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"2593","DOI":"10.1038\/oby.2008.414","article-title":"Increased myocardial susceptibility to repetitive ischemia with high-fat diet-induced obesity","volume":"16","author":"Thakker","year":"2008","journal-title":"Obesity"},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1161\/CIRCHEARTFAILURE.112.966705","article-title":"Agonist-induced hypertrophy and diastolic dysfunction are associated with selective reduction in glucose oxidation: A metabolic contribution to heart failure with normal ejection fraction","volume":"5","author":"Mori","year":"2012","journal-title":"Circ. Heart Fail."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"H1103","DOI":"10.1152\/ajpheart.00636.2012","article-title":"Ang ii causes insulin resistance and induces cardiac metabolic switch and inefficiency: A critical role of pdk4","volume":"304","author":"Mori","year":"2013","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"e12489","DOI":"10.14814\/phy2.12489","article-title":"Diet-induced obesity promotes altered remodeling and exacerbated cardiac hypertrophy following pressure overload","volume":"3","author":"Holzem","year":"2015","journal-title":"Physiol. Rep."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.2337\/db14-1050","article-title":"Lowering body weight in obese mice with diastolic heart failure improves cardiac insulin sensitivity and function: Implications for the obesity paradox","volume":"64","author":"Sankaralingam","year":"2015","journal-title":"Diabetes"},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"e013039","DOI":"10.1161\/JAHA.119.013039","article-title":"Increased glucose availability attenuates myocardial ketone body utilization","volume":"9","author":"Brahma","year":"2020","journal-title":"J. Am. Heart Assoc."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"2094","DOI":"10.2337\/db19-1057","article-title":"Maintaining myocardial glucose utilization in diabetic cardiomyopathy accelerates mitochondrial dysfunction","volume":"69","author":"Wende","year":"2020","journal-title":"Diabetes"},{"key":"ref_93","doi-asserted-by":"crossref","unstructured":"Funada, J., Betts, T.R., Hodson, L., Humphreys, S.M., Timperley, J., Frayn, K.N., and Karpe, F. (2009). Substrate utilization by the failing human heart by direct quantification using arterio-venous blood sampling. PLoS ONE, 4.","DOI":"10.1371\/journal.pone.0007533"},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1161\/CIRCULATIONAHA.115.017355","article-title":"The failing heart relies on ketone bodies as a fuel","volume":"133","author":"Aubert","year":"2016","journal-title":"Circulation"},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1161\/CIRCULATIONAHA.115.017545","article-title":"Evidence for intramyocardial disruption of lipid metabolism and increased myocardial ketone utilization in advanced human heart failure","volume":"133","author":"Bedi","year":"2016","journal-title":"Circulation"},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1016\/0735-1097(96)00214-8","article-title":"Blood ketone bodies in congestive heart failure","volume":"28","author":"Lommi","year":"1996","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_97","doi-asserted-by":"crossref","unstructured":"Du, Z., Shen, A., Huang, Y., Su, L., Lai, W., Wang, P., Xie, Z., Xie, Z., Zeng, Q., and Ren, H. (2014). 1h-nmr-based metabolic analysis of human serum reveals novel markers of myocardial energy expenditure in heart failure patients. PLoS ONE, 9.","DOI":"10.1371\/journal.pone.0088102"},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"2117","DOI":"10.1056\/NEJMoa1504720","article-title":"Empagliflozin, cardiovascular outcomes, and mortality in type 2 diabetes","volume":"373","author":"Zinman","year":"2015","journal-title":"N. Engl. J. Med."},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1056\/NEJMoa1611925","article-title":"Canagliflozin and cardiovascular and renal events in type 2 diabetes","volume":"377","author":"Neal","year":"2017","journal-title":"N. Engl. J. Med."},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"1931","DOI":"10.1016\/j.jacc.2019.01.056","article-title":"Empagliflozin ameliorates adverse left ventricular remodeling in nondiabetic heart failure by enhancing myocardial energetics","volume":"73","author":"Ishikawa","year":"2019","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1111\/jdi.13122","article-title":"Effect of tofogliflozin on cardiac and vascular endothelial function in patients with type 2 diabetes and heart diseases: A pilot study","volume":"11","author":"Tochiya","year":"2020","journal-title":"J. Diabetes Investig."},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1038\/s41569-022-00824-4","article-title":"Sglt2 inhibitors: Role in protective reprogramming of cardiac nutrient transport and metabolism","volume":"20","author":"Packer","year":"2023","journal-title":"Nat. Rev. Cardiol."},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1038\/s41574-025-01170-4","article-title":"Cardiometabolic and renal benefits of sodium-glucose cotransporter 2 inhibitors","volume":"21","author":"Lee","year":"2025","journal-title":"Nat. Rev. Endocrinol."},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"229","DOI":"10.14336\/AD.2019.0510","article-title":"Ketogenic diet ameliorates cardiac dysfunction via balancing mitochondrial dynamics and inhibiting apoptosis in type 2 diabetic mice","volume":"11","author":"Guo","year":"2020","journal-title":"Aging Dis."},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"e020729","DOI":"10.1161\/JAHA.120.020729","article-title":"Ketone ester d-\u03b2-hydroxybutyrate-(r)-1,3 butanediol prevents decline in cardiac function in type 2 diabetic mice","volume":"10","author":"Thai","year":"2021","journal-title":"J. Am. Heart Assoc."},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1007\/s12020-016-1082-7","article-title":"Diabetic ketosis during hyperglycemic crisis is associated with decreased all-cause mortality in patients with type 2 diabetes mellitus","volume":"55","author":"Kruljac","year":"2017","journal-title":"Endocrine"},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1111\/dom.13608","article-title":"Cardiac metabolic modulation upon low-carbohydrate low-protein ketogenic diet in diabetic rats studied in vivo using hyperpolarized 13c pyruvate, butyrate and acetoacetate probes","volume":"21","author":"Abdurrachim","year":"2019","journal-title":"Diabetes Obes. Metab."},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/j.jacbts.2018.07.006","article-title":"Empagliflozin increases cardiac energy production in diabetes: Novel translational insights into the heart failure benefits of sglt2 inhibitors","volume":"3","author":"Verma","year":"2018","journal-title":"JACC Basic. Transl. Sci."},{"key":"ref_109","doi-asserted-by":"crossref","unstructured":"Kosinski, C., and Jornayvaz, F.R. (2017). Effects of ketogenic diets on cardiovascular risk factors: Evidence from animal and human studies. Nutrients, 9.","DOI":"10.3390\/nu9050517"},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.yrtph.2012.04.001","article-title":"Oral 28-day and developmental toxicity studies of (r)-3-hydroxybutyl (r)-3-hydroxybutyrate","volume":"63","author":"Clarke","year":"2012","journal-title":"Regul. Toxicol. Pharmacol."},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/j.yrtph.2012.04.008","article-title":"Kinetics, safety and tolerability of (r)-3-hydroxybutyl (r)-3-hydroxybutyrate in healthy adult subjects","volume":"63","author":"Clarke","year":"2012","journal-title":"Regul. Toxicol. Pharmacol."},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1111\/dom.13577","article-title":"Sodium-glucose cotransporter 2 inhibitors regulate ketone body metabolism via inter-organ crosstalk","volume":"21","author":"Kim","year":"2019","journal-title":"Diabetes Obes. Metab."},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"800","DOI":"10.2337\/db20-0921","article-title":"Sglt2 inhibition does not affect myocardial fatty acid oxidation or uptake, but reduces myocardial glucose uptake and blood flow in individuals with type 2 diabetes: A randomized double-blind, placebo-controlled crossover trial","volume":"70","author":"Lauritsen","year":"2021","journal-title":"Diabetes"},{"key":"ref_114","doi-asserted-by":"crossref","unstructured":"Hu, L., Qiu, C., Wang, X., Xu, M., Shao, X., and Wang, Y. (2018). The association between diabetes mellitus and reduction in myocardial glucose uptake: A population-based 18f-fdg pet\/ct study. BMC Cardiovasc. Disord., 18.","DOI":"10.1186\/s12872-018-0943-9"},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"771","DOI":"10.2337\/dc16-2724","article-title":"Renal handling of ketones in response to sodium-glucose cotransporter 2 inhibition in patients with type 2 diabetes","volume":"40","author":"Ferrannini","year":"2017","journal-title":"Diabetes Care"},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1186\/s12933-021-01410-7","article-title":"Effect of empagliflozin on ketone bodies in patients with stable chronic heart failure","volume":"20","author":"Pietschner","year":"2021","journal-title":"Cardiovasc. Diabetol."}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/27\/13\/5716\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T04:19:23Z","timestamp":1782965963000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/27\/13\/5716"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,24]]},"references-count":116,"journal-issue":{"issue":"13","published-online":{"date-parts":[[2026,7]]}},"alternative-id":["ijms27135716"],"URL":"https:\/\/doi.org\/10.3390\/ijms27135716","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,24]]}}}